Literature DB >> 22183550

Assignment of protonation states in proteins and ligands: combining pKa prediction with hydrogen bonding network optimization.

Elmar Krieger1, Roland L Dunbrack, Rob W W Hooft, Barbara Krieger.   

Abstract

Among the many applications of molecular modeling, drug design is probably the one with the highest demands on the accuracy of the underlying structures. During lead optimization, the position of every atom in the binding site should ideally be known with high precision to identify those chemical modifications that are most likely to increase drug affinity. Unfortunately, X-ray crystallography at common resolution yields an electron density map that is too coarse, since the chemical elements and their protonation states cannot be fully resolved.This chapter describes the steps required to fill in the missing knowledge, by devising an algorithm that can detect and resolve the ambiguities. First, the pK (a) values of acidic and basic groups are predicted. Second, their potential protonation states are determined, including all permutations (considering for example protons that can jump between the oxygens of a phosphate group). Third, those groups of atoms are identified that can adopt alternative but indistinguishable conformations with essentially the same electron density. Fourth, potential hydrogen bond donors and acceptors are located. Finally, all these data are combined in a single "configuration energy function," whose global minimum is found with the SCWRL algorithm, which employs dead-end elimination and graph theory. As a result, one obtains a complete model of the protein and its bound ligand, with ambiguous groups rotated to the best orientation and with protonation states assigned considering the current pH and the H-bonding network. An implementation of the algorithm has been available since 2008 as part of the YASARA modeling & simulation program.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22183550     DOI: 10.1007/978-1-61779-465-0_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  65 in total

1.  Computational docking simulations of a DNA-aptamer for argininamide and related ligands.

Authors:  H Bauke Albada; Eyal Golub; Itamar Willner
Journal:  J Comput Aided Mol Des       Date:  2015-04-16       Impact factor: 3.686

2.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

3.  Homology models of mouse and rat estrogen receptor-α ligand-binding domain created by in silico mutagenesis of a human template: molecular docking with 17ß-estradiol, diethylstilbestrol, and paraben analogs.

Authors:  Thomas L Gonzalez; James M Rae; Justin A Colacino; Rudy J Richardson
Journal:  Comput Toxicol       Date:  2018-11-28

4.  Protein-ligand interfaces are polarized: discovery of a strong trend for intermolecular hydrogen bonds to favor donors on the protein side with implications for predicting and designing ligand complexes.

Authors:  Sebastian Raschka; Alex J Wolf; Joseph Bemister-Buffington; Leslie A Kuhn
Journal:  J Comput Aided Mol Des       Date:  2018-02-12       Impact factor: 3.686

5.  Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX.

Authors:  I Cruz-Torres; D S Backos; P S Herson
Journal:  Mol Pharmacol       Date:  2019-11-26       Impact factor: 4.436

6.  Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines.

Authors:  Thomas L Gonzalez; Rebecca K Moos; Christina L Gersch; Michael D Johnson; Rudy J Richardson; Holger M Koch; James M Rae
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

Review 7.  Protonation and pK changes in protein-ligand binding.

Authors:  Alexey V Onufriev; Emil Alexov
Journal:  Q Rev Biophys       Date:  2013-05       Impact factor: 5.318

8.  (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation.

Authors:  Fabienne C Fiesel; Maya Ando; Roman Hudec; Anneliese R Hill; Monica Castanedes-Casey; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Jeannette N Stankowski; Peter O Bauer; Oswaldo Lorenzo-Betancor; Isidre Ferrer; José M Arbelo; Joanna Siuda; Li Chen; Valina L Dawson; Ted M Dawson; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson; Wolfdieter Springer
Journal:  EMBO Rep       Date:  2015-07-10       Impact factor: 8.807

9.  Phosphorylation of Leukotriene C4 Synthase at Serine 36 Impairs Catalytic Activity.

Authors:  Shabbir Ahmad; A Jimmy Ytterberg; Madhuranayaki Thulasingam; Fredrik Tholander; Tomas Bergman; Roman Zubarev; Anders Wetterholm; Agnes Rinaldo-Matthis; Jesper Z Haeggström
Journal:  J Biol Chem       Date:  2016-06-30       Impact factor: 5.157

10.  Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.

Authors:  Sanam Sane; Ammara Abdullah; Morgan E Nelson; Hongmin Wang; Subhash C Chauhan; Samuel S Newton; Khosrow Rezvani
Journal:  Cell Stress Chaperones       Date:  2015-12-04       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.